Current Neurovascular Research
Title:Circadian Clock Genes: Targeting Innate Immunity for Antiviral Strategies Against COVID-19
Volume: 17 Issue: 5
Author(s): Kenneth Maiese
Affiliation:
Export Options
About this article
Cite this article as:
Maiese Kenneth , Circadian Clock Genes: Targeting Innate Immunity for Antiviral Strategies Against COVID-19, Current Neurovascular Research 2020; 17 (5) . https://dx.doi.org/10.2174/1567202617666201203110008
DOI https://dx.doi.org/10.2174/1567202617666201203110008 |
Print ISSN 1567-2026 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5739 |
Article Metrics

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
ADAM17 as a Therapeutic Target in Multiple Diseases
Current Pharmaceutical Design Physical and Mental Functions of Cardiovascular Diseased Patients Decrease During the State of Emergency Initiated by the COVID-19 Pandemic in Japan
Reviews on Recent Clinical Trials Repositioning of Drugs to Counter COVID-19 Pandemic - An Insight
Current Pharmaceutical Biotechnology Magic Shotgun Nature with Scattergun Approach of Curcumin Repurposing in Obsessive-compulsive Disorder: A Novel Metaphysician of Drug Discovery
CNS & Neurological Disorders - Drug Targets <i>In Silico</i> Investigation of the SARS CoV2 Protease with Thymoquinone, the Major Constituent of <i>Nigella Sativa</i>
Current Drug Discovery Technologies Analyses of Protein Sequences Using Inter-Residue Average Distance Statistics to Study Folding Processes and the Significance of Their Partial Sequences
Protein & Peptide Letters <i>Nigella sativa</i>, as Preventive Strategy in COVID-19
Current Traditional Medicine The Plausible Role of Indian Traditional Medicine in Combating Corona Virus (SARS-CoV 2): A Mini-Review
Current Pharmaceutical Biotechnology Spatial Proteomics Sheds Light on the Biology of Nucleolar Chaperones
Current Proteomics In Vivo and In Vitro Evaluation of the Therapeutic Potential of Some Turkish Scorzonera Species as Wound Healing Agent
Current Pharmaceutical Design Chloroquine as Chemoprophylaxis for COVID-19: Will This Work
Infectious Disorders - Drug Targets Impact of Coronavirus Outbreak on Climate and Air Quality
Current Signal Transduction Therapy Melatonin Could Be Beneficial in SARS-CoV-2 Therapy
The Natural Products Journal A Case Study: Analysis of Patents on Coronaviruses and Covid-19 for Technological Assessment and Future Research
Current Pharmaceutical Design Natural Products: A Rich Source of Antiviral Drug Lead Candidates for the Management of COVID-19
Current Pharmaceutical Design Production, Novel Assay Development and Clinical Applications of Monoclonal Antibodies
Recent Patents on Anti-Cancer Drug Discovery Remdesivir and Hydroxychloroquine: A Compassionate Use in Covid-19
Current Drug Targets Inhibition of S-protein RBD and hACE2 Interaction for Control of SARSCoV- 2 Infection (COVID-19)
Mini-Reviews in Medicinal Chemistry Different Methods for Molecular and Rapid Detection of Human Novel Coronavirus
Current Pharmaceutical Design Preliminary Identification of Hamamelitannin and Rosmarinic Acid as COVID-19 Inhibitors Based on Molecular Docking
Letters in Drug Design & Discovery